Screening compound: OKNMKQUSCVKQCX-LBPRGKRZSA-N

Screening compound: OKNMKQUSCVKQCX-LBPRGKRZSA-N
Screening compound: OKNMKQUSCVKQCX-LBPRGKRZSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
OKNMKQUSCVKQCX-LBPRGKRZSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S428-0497

Molecular Formula

C16H21N5O3 (C16 H21 N5 O3)

Compound Name

(1-methyl-1H-imidazol-2-yl)[2-(3-tetrahydro-2H-pyran-4-yl-1,2,4-oxadiazol-5-yl)-1-pyrrolidinyl]methanone

IUPAC name

5-[1-(1-methyl-1H-imidazole-2-carbonyl)pyrrolidin-2-yl]-3-(oxan-4-yl)-124-oxadiazole

SMILES

Cn1c(C(N(CCC2)C2c2nc(C3CCOCC3)no2)=O)ncc1

InChI

InChI=1S/C16H21N5O3/c1-20-8-6-17-14(20)16(22)21-7-2-3-12(21)15-18-13(19-24-15)11-4-9-23-10-5-11/h6,8,11-12H,2-5,7,9-10H2,1H3/t12-/m0/s1

InChI Key

OKNMKQUSCVKQCX-LBPRGKRZSA-N

MDL Number (MFCD)

MFCD29006759

OKNMKQUSCVKQCX-LBPRGKRZSA-N in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS MPO Library (28609 compounds)

GPCR Targeted Library (31838 compounds)

Ligand-Gated Ion Channels Library (3887 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

Neuropeptide S Library (2850 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Nervous system
  • Eye
  • Cancer
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
  • Digestive system
  • Nervous system
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
  • Receptor's ligands
Targets:
  • GPCR
  • Ion Channels
  • GPCR
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with OKNMKQUSCVKQCX-LBPRGKRZSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound OKNMKQUSCVKQCX-LBPRGKRZSA-N?
Check Price and Availability of OKNMKQUSCVKQCX-LBPRGKRZSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of OKNMKQUSCVKQCX-LBPRGKRZSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for OKNMKQUSCVKQCX-LBPRGKRZSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for OKNMKQUSCVKQCX-LBPRGKRZSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of OKNMKQUSCVKQCX-LBPRGKRZSA-N available by request